Bringing Greater Efficiency to Your Biobank Laboratory
Sponsored content brought to you by
The growing importance of biobanks cannot be overstated and is increasing the pressure placed on these facilities to deliver larger quantities of high-quality samples from their repositories. Facilities that...
Successful EFIB in Brussels – European Biotechnology
How can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels.
More than 260 companies with 480 delegates from 30 countries joined...
Antibiotic-Resistant Bacteria Tickle the Phage’s Engineered Tail
Researchers at MIT have resolved that bacterial resistance should be overcome by hook or by hook. The hooks, in this case, are tail fibers, structures that bacteriophages use to snag bacteria and set them...
Protein associated with many diseases fully visualized for first time
New drugs could be inspired by understanding how P2X7 protein receptor works
Credit: Oregon Health & Science University
For the first time, researchers have observed at the molecular...
Potential Drug Offers New Approach to Treating Heart Attacks and Preventing Heart Failure
Researchers from the University of Guelph say they are working on a potential new drug to treat heart attacks and prevent heart failure. Tami Martino, PhD, professor of biomedical sciences and director of the...
How to become a biotechnology entrepreneur – Garth Rapeport – The London Economic
Garth Rapeport co-founder and CEO of Pulmocide Ltd, a well-established biotech. Previously co-founder of Respivert, which was subsequently acquired by a subsidiary of Johnson&Johnson, he is well-placed to advise on the challenges facing a...
UCR biochemist receives grant to develop novel lead compound to treat breast cancer
A biochemist at the University of California, Riverside, has received a grant from the Congressionally Directed Medical Research Programs, or CDMRP, of the U.S. Department of Defense to develop a novel lead compound to...
Adding local anesthetics can improve treatment for incurable breast cancer, melanoma
A new study examined the effects of local anesthetics combined with standard chemotherapy for treatment of incurable triple-negative (TN) breast cancer, as well as melanoma. The results suggest that the combined treatment can lower...
Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company
Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research,...
Pioneering red light-activated anti-tumor prodrug reduces side effects
Credit: Wang et al., Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red
Light, Chem (2019), https://doi.org/10.1016/j.chempr.2019.08.021…
Most of the current clinical anti-tumor drugs used in chemotherapy move around in the...
